Related Experiment Video
Updated: Sep 27, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Asthma in the school-aged child
Mary Beth Hogan1, Nevin W Wilson
1Section of Pediatric Allergy and Immunology, Department of Pediatrics, Robert C. Byrd Health Science Center, West Virginia University, Morgantown, WV 26506-9214, USA.
Insights
Effective childhood asthma management focuses on inhaled anti-inflammatory medications and environmental controls. Improving patient adherence through education is crucial for reducing asthma
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Public Health
Background:
- Childhood asthma management has evolved, emphasizing inflammation control.
- National Institutes of Health (NIH) guidelines recommend inhaled long-term control medications.
- These medications are crucial for children with frequent or nocturnal asthma symptoms.
Purpose of the Study:
- To highlight the importance of inflammation-targeted therapies in pediatric asthma.
- To underscore the role of environmental control and co-existing conditions like sinusitis and GER.
- To identify and address barriers to effective asthma care, particularly patient non-compliance.
Main Methods:
- Review of current NIH guidelines for childhood asthma management.
- Analysis of factors contributing to poor patient adherence to asthma treatment plans.
- Emphasis on patient education and physician adherence to guidelines.
Main Results:
- Inhaled long-term control medications are the cornerstone of asthma treatment for eligible children.
- Environmental control and management of comorbidities are essential components of care.
- Poor patient compliance, stemming from lack of understanding, dosing issues, and side effect fears, is a significant impediment.
Conclusions:
- Improved patient education is vital to enhance adherence to prophylactic asthma medications.
- Physician adherence to NIH guidelines is also critical for optimal outcomes.
- Addressing compliance issues is key to reducing childhood asthma morbidity and mortality.
Abstract:
Understanding the role of inflammation in childhood asthma has led to major changes in the approach to management of this disease. Based on the guidelines from the NIH, inhaled long-term control medications that target the underlying inflammatory processes in asthma are now recommended as the mainstay of drug treatment. Long-term control medications are recommended for all children who have asthma symptoms that occur more frequently than twice weekly or nocturnal symptoms more than twice monthly. Environmental control measures to decrease allergen exposure are important, as is attention to sinusitis and GER. The main impediment to improved asthma care is poor patient compliance. Many patients do not understand the role and importance of prophylactic medications in asthma treatment. Further, inconvenient dosing regimens, difficulties with metered-dose inhalers, and fear of potential side effects have all contributed to poor patient compliance. Increased efforts at patient education are needed to improve adherence to asthma plans. These efforts at improving patient compliance, along with improved physician adherence to the guidelines from the NIH, are needed to decrease the morbidity and mortality of childhood asthma.
Related Concept Videos
Asthma I: Introduction
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations
Asthma-III: Symptoms and Complications
Classification of Asthma